Trademarkia Logo

Canada

C$
Trademark Search in Canada
RAZTAMRI

View On IC.GC.CA

RAZTAMRI
SEARCHED

on 16 Jan 2025

Last Applicant/ Owned by

SYROS Pharmaceuticals, Inc.

35 CambridgePark Drive, 4th FloorCambridge MA 02140

US

Serial Number

2288059 filed on 22nd Sept 2023

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

RAZTAMRI

Trademark usage description

pharmaceutical products; pharmaceuticals for treatment of myelodysplastic syndrome; pharmaceuticals for treatment of acute myeloid leukemia, acute mye Read More

Classification Information

Class [005]
Pharmaceutical products; pharmaceuticals for treatment of myelodysplastic syndrome; pharmaceuticals for treatment of acute myeloid leukemia, acute myelogenous leukemia, and acute nonlymphocytic leukemia.

Classification kind code

12

Mark Details

Serial Number

2288059

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 22
on 16th Jan 2025		Search Recorded
Submitted for opposition 20
on 16th Jan 2025		Examiner's First Report
Submitted for opposition 223
on 16th Jan 2025		Total Provisional Refusal
Submitted for opposition 256
on 19th Aug 2024		Notification of Possible Opposition Sent
Submitted for opposition 48
on 8th Nov 2023		Agent Changed
Submitted for opposition 257
on 19th Oct 2023		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 18th Oct 2023		Formalized
Submitted for opposition 1
on 18th Oct 2023		Created
Submitted for opposition 228
on 22nd Sept 2023		International Registration
Submitted for opposition 30
on 22nd Sept 2023		Filed